Vyhledat publikace
Chasák, J.; Oorts, L.; Dak, M.; Šlachtová, V.; Bazgier, V.; Berka, K.; De Vooght, L.; Smiejkowska, N.; Van Calster, K.; Van Moll, L.; Cappoen, D.; Cos, P.; Brulíková, L.*
Expanding the squaramide library as mycobacterial ATP synthase inhibitors: innovative synthetic pathway and biological evaluation
Bioorg. Med. Chem. 2023, 95 (-), 117504(1-18). DOI: 10.1016/j.bmc.2023.117504
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.*
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function
Eur. J. Med. Chem. 2022, 244 (-), 114831 (1-15). DOI: 10.1016/j.ejmech.2022.114831
Brulíková, L.; Chasák, J.; Dak, M.; Šlachtová, V.; Cappoen, D.; Šebela, M.; Berka, K.; Bazgier, V.
New agents for the treatment of drug-resistant Mycobacterium tubercculosis
74. sjezd českých a slovenských chemických společností, September 4 – 7, 2022, Olomouc, přednáška .
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1
56th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 10 – 12, 2022, Špindlerův mlýn, poster .
Šlachtová, V.; Dak, M.; Šebela, M.; Cappoen, D.; Berka, K; Bazgier, V.; Brulíková, L.
Synthesis of novel potential mycobacterial Zmp1 inhibitors
56th International Conference on Medicinal Chemistry, July 7 – 9, 2021, virtual event, poster .
Chasák, J.; Dak, M.; Berka, K.; Bazgier, V.; Cappoen, D.; Brulíková, L.
Design and synthesis of new squaramides as mycobacterial ATP synthase inhibitors
55th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 3 – 6, 2021, Špindlerův mlýn, poster .